Manifestations of Hereditary Multiple Exostoses
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Advances in the Pathogenesis and Possible Treatments for Multiple Hereditary Exostoses from the 2016 International MHE Conference
Connective Tissue Research ISSN: 0300-8207 (Print) 1607-8438 (Online) Journal homepage: https://www.tandfonline.com/loi/icts20 Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference Anne Q. Phan, Maurizio Pacifici & Jeffrey D. Esko To cite this article: Anne Q. Phan, Maurizio Pacifici & Jeffrey D. Esko (2018) Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference, Connective Tissue Research, 59:1, 85-98, DOI: 10.1080/03008207.2017.1394295 To link to this article: https://doi.org/10.1080/03008207.2017.1394295 Published online: 03 Nov 2017. Submit your article to this journal Article views: 323 View related articles View Crossmark data Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=icts20 CONNECTIVE TISSUE RESEARCH 2018, VOL. 59, NO. 1, 85–98 https://doi.org/10.1080/03008207.2017.1394295 PROCEEDINGS Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference Anne Q. Phana, Maurizio Pacificib, and Jeffrey D. Eskoa aDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA; bTranslational Research Program in Pediatric Orthopaedics, Division of Orthopaedic Surgery, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA ABSTRACT KEYWORDS Multiple hereditary exostoses (MHE) is an autosomal dominant disorder that affects about 1 in 50,000 Multiple hereditary children worldwide. MHE, also known as hereditary multiple exostoses (HME) or multiple osteochon- exostoses; multiple dromas (MO), is characterized by cartilage-capped outgrowths called osteochondromas that develop osteochondromas; EXT1; adjacent to the growth plates of skeletal elements in young patients. -
Upper Jaw Chronic Osteomyelitis. Report of Four Clinical Cases Osteomielitis Crónica Maxilar
www.medigraphic.org.mx Revista Odontológica Mexicana Facultad de Odontología Vol. 16, No. 2 April-June 2012 pp 105-111 CASE REPORT Upper jaw chronic osteomyelitis. Report of four clinical cases Osteomielitis crónica maxilar. Informe de 4 casos clínicos Alberto Wintergerst Fish,* Carlos Javier Iturralde Espinosa,§ Vladimir de la Riva Parra,II Santiago Reinoso QuezadaII ABSTRACT RESUMEN Osteomyelitis is an infl ammatory bone disease commonly related La osteomielitis es una enfermedad ósea infl amatoria, comúnmente to an infectious origin caused by germs, mainly pyogenic staphy- relacionada a un origen infeccioso por gérmenes piógenos funda- lococcus, and occasionally, streptococci, pneumococci and en- mentalmente estafi lococos y en algunas ocasiones por estreptoco- terobacteriae. Several treatments and classifi cations for osteomy- cos, neumococos y enterobacterias. Se han establecido diversas elitis have been established. These are based on clinical course, clasifi caciones y tratamientos para la osteomielitis, basadas en el pathologic-anatomical or radiologic features, etiology and patho- comportamiento clínico, características anatomo-patológicas, ra- genesis. Chronic osteomyelitis is a complication of non-treated or diográfi cas, etiología y patogenia. La osteomielitis crónica es una inadequately treated acute osteomyleitis. It can also be caused by a complicación de la osteomielitis aguda no tratada, manejada inade- low grade prolonged infl ammatory reaction. This study presents four cuadamente o como una reacción infl amatoria prolongada de bajo cases of maxillary osteomyelitis treated between 2007 and 2009. grado. Se presentan 4 casos de osteomielitis crónica en el maxilar Cases were treated with antimicrobial therapy. Preoperatively, pa- tratadas entre 2007 y 2009 mediante terapia antimicrobiana preo- tients were prescribed Clindamycin, 300 mg every eight hours, Ce- peratoriamente con clindamicina 300 mg, IV cada 8 h y ceftriaxona friaxone, 1 g IV every 12 hours. -
Exostoses, Enchondromatosis and Metachondromatosis; Diagnosis and Management
Acta Orthop. Belg., 2016, 82, 102-105 ORIGINAL STUDY Exostoses, enchondromatosis and metachondromatosis; diagnosis and management John MCFARLANE, Tim KNIGHT, Anubha SINHA, Trevor COLE, Nigel KIELY, Rob FREEMAN From the Department of Orthopaedics, Robert Jones Agnes Hunt Hospital, Oswestry, UK We describe a 5 years old girl who presented to the region of long bones and are composed of a carti- multidisciplinary skeletal dysplasia clinic following lage lump outside the bone which may be peduncu- excision of two bony lumps from her fingers. Based on lated or sessile, the knee is the most common clinical examination, radiolographs and histological site (1,10). An isolated exostosis is a common inci- results an initial diagnosis of hereditary multiple dental finding rarely requiring treatment. Disorders exostosis (HME) was made. Four years later she developed further lumps which had the radiological associated with exostoses include HME, Langer- appearance of enchondromas. The appearance of Giedion syndrome, Gardner syndrome and meta- both exostoses and enchondromas suggested a possi- chondromatosis. ble diagnosis of metachondromatosis. Genetic testing Enchondroma are the second most common be- revealed a splice site mutation at the end of exon 11 on nign bone tumour characterised by the formation of the PTPN11 gene, confirming the diagnosis of meta- hyaline cartilage in the medulla of a bone. It occurs chondromatosis. While both single or multiple exosto- most frequently in the hand (60%) and then the feet. ses and enchondromas occur relatively commonly on The typical radiological features are of a well- their own, the appearance of multiple exostoses and defined lucent defect with endosteal scalloping and enchondromas together is rare and should raise the differential diagnosis of metachondromatosis. -
Osteomalacia and Osteoporosis D
Postgrad. med.J. (August 1968) 44, 621-625. Postgrad Med J: first published as 10.1136/pgmj.44.514.621 on 1 August 1968. Downloaded from Osteomalacia and osteoporosis D. B. MORGAN Department of Clinical Investigation, University ofLeeds OSTEOMALACIA and osteoporosis are still some- in osteomalacia is an increase in the alkaline times confused because both diseases lead to a phosphatase activity in the blood (SAP); there deficiency of calcium which can be detected on may also be a low serum phosphorus or a low radiographs of the skeleton. serum calcium. This lack of calcium is the only feature Our experience with the biopsy of bone is that common to the two diseases which are in all a large excess of uncalcified bone tissue (osteoid), other ways easily distinguishable. which is the classic histological feature of osteo- malacia, is only found in patients with the other Osteomalacia typical features of the disease, in particular the Osteomalacia will be discussed first, because it clinical ones (Morgan et al., 1967a). Whether or is a clearly defined disease which can be cured. not more subtle histological techniques will detect Osteomalacia is the result of an imbalance be- earlier stages of the disease remains to be seen. tween the supply of and the demand for vitamin Bone pains, muscle weakness, Looser's zones, D. The the following description of disease is raised SAP and low serum phosphate are the Protected by copyright. based on our experience of twenty-two patients most reliable aids to the diagnosis of osteomalacia, with osteomalacia after gastrectomy; there is no and approximately in that order. -
Final Copy 2020 09 29 Mania
This electronic thesis or dissertation has been downloaded from Explore Bristol Research, http://research-information.bristol.ac.uk Author: Maniaki, Evangelia Title: Risk factors, activity monitoring and quality of life assessment in cats with early degenerative joint disease General rights Access to the thesis is subject to the Creative Commons Attribution - NonCommercial-No Derivatives 4.0 International Public License. A copy of this may be found at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode This license sets out your rights and the restrictions that apply to your access to the thesis so it is important you read this before proceeding. Take down policy Some pages of this thesis may have been removed for copyright restrictions prior to having it been deposited in Explore Bristol Research. However, if you have discovered material within the thesis that you consider to be unlawful e.g. breaches of copyright (either yours or that of a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, libel, then please contact [email protected] and include the following information in your message: •Your contact details •Bibliographic details for the item, including a URL •An outline nature of the complaint Your claim will be investigated and, where appropriate, the item in question will be removed from public view as soon as possible. RISK FACTORS, ACTIVITY MONITORING AND QUALITY OF LIFE ASSESSMENT IN CATS WITH EARLY DEGENERATIVE JOINT DISEASE Evangelia Maniaki A dissertation submitted to the University of Bristol in accordance with the requirements for award of the degree of Master’s in Research in the Faculty of Health Sciences Bristol Veterinary School, June 2020 Twenty-nine thousand two hundred and eighteen words 1. -
Ch07 Final.Qxd 7/2/07 13:55 Page 87
Ch07 final.qxd 7/2/07 13:55 Page 87 87 CHAPTER 7 ARTHROLOGY Feline arthrology has been an overlooked subject in term osteoarthritis is reserved for the specific type of the past with most reviews of joint disease in small DJD that affects diarthrodial synovial articulations. animals focusing on the dog. However, cats are now Diseases of synovial joints can conveniently be known to suffer from many different types of joint divided into degenerative arthritis and inflammatory disease and, although there are many similarities with arthritis on the basis of the predominant pathologic the dog, there are also many features that are unique process (Table 20). Degenerative arthropathies are the to the feline patient. most common types and include traumatic arthritis and osteoarthritis. Inflammatory arthropathies are less CLASSIFICATION OF JOINT DISEASE common than degenerative arthropathies and have The terms arthritis and arthropathy literally mean joint either an infective or immune-mediated etiology. inflammation and joint disease, respectively. These terms Infective arthritis caused by bacterial infection (septic are used interchangeably in this chapter to describe arthritis) is the commonest type of inflammatory arthritis a number of well defined joint diseases characterized in the cat. Septic arthritis is classed as an erosive type of by a combination of inflammatory and degenerative arthritis because there is destruction of articular cartilage changes. The terms degenerative joint disease (DJD) in joints infected by bacteria. Immune-mediated and osteoarthritis are also often used synonymously. In arthropathies can be subdivided into both erosive this chapter, DJD is used as a general descriptive term to and nonerosive forms. -
Ollier Disease: a Case Report
Case Report Ollier Disease: A Case Report Bajracharya L*, Shrestha M**, Paudel S***, Shrestha PS*** *Teaching Assistant, **Assistant Professor, Department of Paediatrics, ***Assistant Professor, Department of Radiology, ****Professor, Department of Paediatrics, TUTH, Kathmandu, Nepal. ABSTRACT Ollier disease is a rare disease featuring multi ple enchondromas mainly aff ecti ng limbs. We describe a boy who presented in our OPD with multi ple painless joint deformiti es mostly in the both upper and lower limbs. Conventi onal X-ray evaluati on revealed typical multi ple radiolucent, homogenous oval and elongated shapes in the deformed limbs. : Ollier Disease , Enchondromatosis INTRODUCTION Enchondromas are common, benign, usually deformity of limbs. There is no history of weight asymptomati c carti lage tumours that develop in loss or traumati c injury. There is no similar family metaphyses and may also involve the diaphysis of history . He is acti ve , appropriate in all domains of long tubular bones.1 Ollier disease is defi ned by the development except delayed motor milestones, short presence of multi ple enchondromas and characterized limb gait and postural lumbar scoliosis. His vitals are by an asymmetric distributi on of carti lage lesions which stable. Weight is 20kg and height is 106cm (both less can be extremely variable. 2 The prevalence of Ollier’s than 3rd percenti le of NCHS). His head circumference disease is esti mated to be 1/100000 .1Children with is 52cm (50th percenti le). Upper segment to lower symptomati c enchondromatosis cases usually present segment rati o is 0.89cm. Multi ple joints are swollen before puberty with deformity, growth disorders and but nontender and non-erythematous. -
SKELETAL DYSPLASIA Dr Vasu Pai
SKELETAL DYSPLASIA Dr Vasu Pai Skeletal dysplasia are the result of a defective growth and development of the skeleton. Dysplastic conditions are suspected on the basis of abnormal stature, disproportion, dysmorphism, or deformity. Diagnosis requires Simple measurement of height and calculation of proportionality [<60 inches: consideration of dysplasia is appropriate] Dysmorphic features of the face, hands, feet or deformity A complete physical examination Radiographs: Extremities and spine, skull, Pelvis, Hand Genetics: the risk of the recurrence of the condition in the family; Family evaluation. Dwarf: Proportional: constitutional or endocrine or malnutrition Disproportion [Trunk: Extremity] a. Height < 42” Diastrophic Dwarfism < 48” Achondroplasia 52” Hypochondroplasia b. Trunk-extremity ratio May have a normal trunk and short limbs (achondroplasia), Short trunk and limbs of normal length (e.g., spondylo-epiphyseal dysplasia tarda) Long trunk and long limbs (e.g., Marfan’s syndrome). c. Limb-segment ratio Normal: Radius-Humerus ratio 75% Tibia-Femur 82% Rhizomelia [short proximal segments as in Achondroplastics] Mesomelia: Dynschondrosteosis] Acromelia [short hands and feet] RUBIN CLASSIFICATION 1. Hypoplastic epiphysis ACHONDROPLASTIC Autosomal Dominant: 80%; 0.5-1.5/10000 births Most common disproportionate dwarfism. Prenatal diagnosis: 18 weeks by measuring femoral and humeral lengths. Abnormal endochondral bone formation: zone of hypertrophy. Gene defect FGFR fibroblast growth factor receptor 3 . chromosome 4 Rhizomelic pattern, with the humerus and femur affected more than the distal extremities; Facies: Frontal bossing; Macrocephaly; Saddle nose Maxillary hypoplasia, Mandibular prognathism Spine: Lumbar lordosis and Thoracolumbar kyphosis Progressive genu varum and coxa valga Wedge shaped gaps between 3rd and 4th fingers (trident hands) Trident hand 50%, joint laxity Pathology Lack of columnation Bony plate from lack of growth Disorganized metaphysis Orthopaedics 1. -
Multiple Hereditary Exostoses
Multiple Hereditary Exostoses Dror Paley MD, FRCSC Medical Director, Paley Orthopedic and spine Institute, St. Mary’s Medical Center, West palm Beach, FL David Feldman, MD Director, Spinal deformity center, Paley Orthopedic and spine Institute, St. Mary’s Medical Center, West palm Beach, FL Multiple hereditary exostoses (MHE), also known as multiple osteochondromas (MO), is an autosomal dominant skeletal disorder. Approximately 10–20% of individuals are a result of a spontaneous mutation while the rest are familial. The prevalence of MHE/MO is 1/50 000. There are two known genes found to cause MHE/MO, EXT1 located on chromosome 8q23-q24 and EXT2 located on chromosome 11p11-p12. In 10–15% of the patients, no mutation can be located by current methods of genetic testing.1–7 These mutations are scattered across both genes. EXT1/EXT2 is essential for the biosynthesis of heparan sulfate (HS). HS production in patients’ cells is reduced by 50% or more.8–19 MHE/MO is associated with characteristic progressive skeletal deformities of the extremities and shortening of one or both the sides, leading to limb length discrepancy (LLD) and short stature.20–28 Two bone segments, such as the lower leg or forearm, are at greater risk of problems due to either osteochondromas (OCs) from one or both bones impinging on or deforming the other bone or a primary issue of altered growth causing one bone to grow at a faster or slower rate. OCs can also affect joint motion due to impingement of an OC with the opposite side of the joint or subluxation/dislocation related to deformity, impingement, and incongruity.20,24,26,29,30 OCs can also cause nerve or vessel entrapment and/or compression, including the spinal cord and nerve roots. -
(Ollier Disease, Maffucci Syndrome) Is Not Caused by the PTHR1 Mutation
Enchondromatosis (Ollier Disease, Maffucci Syndrome) Is Not Caused by the PTHR1 Mutation p.R150C Bovée, J.V.M.G.; Rozeman, L.B.; Sangiorgi, L.; Briaire-de Bruijn, I.H.; Mainil-Varlet, P.; Bertoni, F.; ... ; Hogendoorn, P.C.W. Citation Bovée, J. V. M. G., Rozeman, L. B., Sangiorgi, L., Briaire-de Bruijn, I. H., Mainil-Varlet, P., Bertoni, F., … Hogendoorn, P. C. W. (2004). Enchondromatosis (Ollier Disease, Maffucci Syndrome) Is Not Caused by the PTHR1 Mutation p.R150C. Human Mutation, 24, 466-473. Retrieved from https://hdl.handle.net/1887/8144 Version: Not Applicable (or Unknown) License: Downloaded from: https://hdl.handle.net/1887/8144 Note: To cite this publication please use the final published version (if applicable). HUMAN MUTATION 24:466^473 (2004) RAPID COMMUNICATION Enchondromatosis (Ollier Disease, Maffucci Syndrome) Is Not Caused by the PTHR1 Mutation p.R150C Leida B. Rozeman,1 Luca Sangiorgi,2 Inge H. Briaire-de Bruijn,1 Pierre Mainil-Varlet,3 F. Bertoni,4 Anne Marie Cleton-Jansen,1 Pancras C.W. Hogendoorn,1 and Judith V.M.G. Bove´e1* 1Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; 2Laboratory of Oncology Research, Rizzoli Orthopedic Institute, Bologna, Italy; 3Institute of Pathology, University of Bern, Bern, Switzerland; 4Department of Pathology, Rizzoli Orthopedic Institute, Bologna, Italy Communicated by Arnold Munnich Enchondromatosis (Ollier disease, Maffucci syndrome) is a rare developmental disorder characterized by multiple enchondromas. Not much is known about its molecular genetic background. Recently, an activating mutation in the parathyroid hormone receptor type 1 (PTHR1) gene, c.448C>T (p.R150C), was reported in two of six patients with enchondromatosis. -
Osteopetrosis J
Arch Dis Child: first published as 10.1136/adc.46.247.257 on 1 June 1971. Downloaded from Archives of Disease in Childhood, 1971, 46, 257. Osteopetrosis J. S. YU,* R. K. OATES, K. HELEN WALSH, and SUSAN J. STUCKEY From the Department of Child Health, University of Sydney, and Department of Dietetics, Royal Alexandra Hospital for Children, Camperdown, N.S.W., Australia Yu, J. S., Oates, R. K., Walsh, K. H., and Stuckey, S. J. (1971). Archives of Disease in Childhood, 46, 257. Osteopetrosis. The clinical histories of nine children with osteopetrosis are reported. Two of them had the malignant infantile variety of the disease: one died within 3 months of birth and the other has survived 20 months on a regimen of a low calcium intake, cellulose phosphate, and steroids. The beneficial effect of a low calcium intake, in early infancy, is supported by the clinical course in the infant with the malignant variety and in another child with the more benign form of the disease. No calcium balance studies were performed. This study suggests that the active measures outlined may favourably influence the haematological and osteosclerotic course of the disease, pending further know- ledge of its aetiological basis, and more specific therapy. Osteopetrosis or marble bone disease is a rare positive calcium balance with a diet low in calcium metabolic bone disease characterized by dense and with steroids (Morrow et al., 1967). This bones (Albers-Schonberg, 1904; Karshner, 1926). approach to management has been recently criti- copyright. Two varieties have been clearly defined-an cized by Cohen (Children's Hospital Medical infantile progressive disease and a milder benign Center, Boston, 1965). -
Hematological Diseases and Osteoporosis
International Journal of Molecular Sciences Review Hematological Diseases and Osteoporosis , Agostino Gaudio * y , Anastasia Xourafa, Rosario Rapisarda, Luca Zanoli , Salvatore Santo Signorelli and Pietro Castellino Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; [email protected] (A.X.); [email protected] (R.R.); [email protected] (L.Z.); [email protected] (S.S.S.); [email protected] (P.C.) * Correspondence: [email protected]; Tel.: +39-095-3781842; Fax: +39-095-378-2376 Current address: UO di Medicina Interna, Policlinico “G. Rodolico”, Via S. Sofia 78, 95123 Catania, Italy. y Received: 29 April 2020; Accepted: 14 May 2020; Published: 16 May 2020 Abstract: Secondary osteoporosis is a common clinical problem faced by bone specialists, with a higher frequency in men than in women. One of several causes of secondary osteoporosis is hematological disease. There are numerous hematological diseases that can have a deleterious impact on bone health. In the literature, there is an abundance of evidence of bone involvement in patients affected by multiple myeloma, systemic mastocytosis, thalassemia, and hemophilia; some skeletal disorders are also reported in sickle cell disease. Recently, monoclonal gammopathy of undetermined significance appears to increase fracture risk, predominantly in male subjects. The pathogenetic mechanisms responsible for these bone loss effects have not yet been completely clarified. Many soluble factors, in particular cytokines that regulate bone metabolism, appear to play an important role. An integrated approach to these hematological diseases, with the help of a bone specialist, could reduce the bone fracture rate and improve the quality of life of these patients.